262 related articles for article (PubMed ID: 37156668)
21. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
22. Association between blood pressure and different antihypertensive drugs with outcome after ischemic stroke: A Mendelian randomization study.
Liu H; Zhang X; Zhou Y; Nguyen TN; Zhang L; Xing P; Li Z; Shen H; Zhang Y; Hua W; Xu H; Zhu X; Chen L; Zuo Q; Zhao R; Li Q; Dai D; Zhang Y; Xu Y; Huang Q; Liu J; Yang P
Int J Stroke; 2023 Dec; 18(10):1247-1254. PubMed ID: 37337369
[TBL] [Abstract][Full Text] [Related]
23. Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study.
Walker VM; Kehoe PG; Martin RM; Davies NM
Int J Epidemiol; 2020 Aug; 49(4):1132-1140. PubMed ID: 31335937
[TBL] [Abstract][Full Text] [Related]
24. Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study.
Zhao C; Feng JL; Deng S; Wang XP; Fu YJ; Wang B; Li HS; Meng FC; Wang JS; Wang X
Front Cardiovasc Med; 2023; 10():1157467. PubMed ID: 37363097
[TBL] [Abstract][Full Text] [Related]
25. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.
Seleme VB; Marques GL; Mendes AEM; Rotta I; Pereira M; Júnior EL; da Cunha CLP
Am J Cardiovasc Drugs; 2021 Mar; 21(2):165-180. PubMed ID: 32710438
[TBL] [Abstract][Full Text] [Related]
26. Using Mendelian randomization study to assess the renal effects of antihypertensive drugs.
Zhao JV; Schooling CM
BMC Med; 2021 Mar; 19(1):79. PubMed ID: 33766008
[TBL] [Abstract][Full Text] [Related]
27. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
28. Hypertension, antihypertensive drugs, and age at onset of Huntington's disease.
Zhu Y; Li M; Bai J; Wang H; Huang X
Orphanet J Rare Dis; 2023 May; 18(1):125. PubMed ID: 37226269
[TBL] [Abstract][Full Text] [Related]
29. Repurposing Antihypertensive Drugs for the Prevention of Glaucoma: A Mendelian Randomization Study.
Liu J; Li S; Hu Y; Qiu S
Transl Vis Sci Technol; 2022 Oct; 11(10):32. PubMed ID: 36264650
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
31. Hypertension in elderly--an overview.
Bhattacharyya A; Das P
J Indian Med Assoc; 1999 Mar; 97(3):96-101. PubMed ID: 10652909
[TBL] [Abstract][Full Text] [Related]
32. Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2 × 2 factorial Mendelian randomization analyses.
Li Y; Liu H; Shen C; Li J; Liu F; Huang K; Gu D; Li Y; Lu X
BMC Med; 2024 May; 22(1):201. PubMed ID: 38764043
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure lowering effects of β-blockers as add-on or combination therapy: A meta-analysis of randomized controlled trials.
Guo QH; Zhu ZM; Feng YQ; Lin JX; Wang JG
J Clin Hypertens (Greenwich); 2023 Mar; 25(3):227-237. PubMed ID: 36756690
[TBL] [Abstract][Full Text] [Related]
34. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
[TBL] [Abstract][Full Text] [Related]
35. Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study.
Kazmi N; Valeeva EV; Khasanova GR; Lewis SJ; Plotnikov D;
Cancer Causes Control; 2023 Aug; 34(8):725-734. PubMed ID: 37178364
[TBL] [Abstract][Full Text] [Related]
36. [Modeling of systolic blood pressure reaction to antihypertensive agents in people with hypertension].
Wu Y; Li YS; Bejan-Angoulvant T; Gueyffier F
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):309-14. PubMed ID: 21624305
[TBL] [Abstract][Full Text] [Related]
37. Calcium channel blockers shorten the periodicity of ultradian variation in blood pressure in patients with essential hypertension.
Kawamura H; Mitsubayashi H; Saito T; Kanmatsuse K; Saito N
Hypertens Res; 1998 Sep; 21(3):179-86. PubMed ID: 9786602
[TBL] [Abstract][Full Text] [Related]
38. Association of antihypertensive drugs with fracture and bone mineral density: A comprehensive drug-target Mendelian randomization study.
Huang X; Zhang T; Guo P; Gong W; Zhu H; Zhao M; Yuan Z
Front Endocrinol (Lausanne); 2023; 14():1164387. PubMed ID: 37056679
[TBL] [Abstract][Full Text] [Related]
39. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
40. Comparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study.
Bronsert MR; Henderson WG; Valuck R; Hosokawa P; Hammermeister K
J Am Board Fam Med; 2013; 26(5):529-38. PubMed ID: 24004705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
